Your browser doesn't support javascript.
loading
Deterioration and Mortality Risk of COPD Patients Not Fitting into Standard GOLD Categories: Results of the COSYCONET Cohort.
Mayerhofer, Barbara; Jörres, Rudolf A; Lutter, Johanna I; Waschki, Benjamin; Kauffmann-Guerrero, Diego; Alter, Peter; Trudzinski, Franziska Christina; Herth, Felix J F; Holle, Rolf; Behr, Jürgen; Bals, Robert; Welte, Tobias; Watz, Henrik; Vogelmeier, Claus F; Kahnert, Kathrin.
Afiliação
  • Mayerhofer B; Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M), Ludwig-Maximilians-Universität München, Munich, Germany.
  • Jörres RA; Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M), Ludwig-Maximilians-Universität München, Munich, Germany.
  • Lutter JI; Institute of Health Economics and Health Care Management, Helmholtz Zentrum München GmbH - German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Germany.
  • Waschki B; Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
  • Kauffmann-Guerrero D; Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Alter P; Department of Internal Medicine V, Comprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), University of Munich (LMU), Munich, Germany.
  • Trudzinski FC; Department of Medicine, Pulmonary and Critical Care Medicine, Philipps-University Marburg, Member of the German Center for Lung Research (DZL), University Medical Center Giessen and Marburg, Marburg, Germany.
  • Herth FJF; Thoraxklinik-Heidelberg gGmbH, Translational Lung Research Centre Heidelberg (TLRC), Member of the German Center for Lung Research Röntgenstraße 1, Heidelberg, Germany.
  • Holle R; Thoraxklinik-Heidelberg gGmbH, Translational Lung Research Centre Heidelberg (TLRC), Member of the German Center for Lung Research Röntgenstraße 1, Heidelberg, Germany.
  • Behr J; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Ludwig-Maximilians-University Munich (LMU), Munich, Germany.
  • Bals R; Department of Internal Medicine V, Comprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), University of Munich (LMU), Munich, Germany.
  • Welte T; Department of Internal Medicine V - Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
  • Watz H; Department of Pneumology, Hannover Medical School, Hannover, Germany.
  • Vogelmeier CF; Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Kahnert K; Department of Medicine, Pulmonary and Critical Care Medicine, Philipps-University Marburg, Member of the German Center for Lung Research (DZL), University Medical Center Giessen and Marburg, Marburg, Germany.
Respiration ; 100(4): 308-317, 2021.
Article em En | MEDLINE | ID: mdl-33486499
BACKGROUND: Patients with COPD-specific symptoms and history but FEV1/FVC ratio ≥0.7 are a heterogeneous group (former GOLD grade 0) with uncertainties regarding natural history. OBJECTIVE: We investigated which lung function measures and cutoff values are predictive for deterioration according to GOLD grades and all-cause mortality. METHODS: We used visit 1-4 data of the COSYCONET cohort. Logistic and Cox regression analyses were used to identify relevant parameters. GOLD 0 patients were categorized according to whether they maintained grade 0 over the following 2 visits or deteriorated persistently into grades 1 or 2. Their clinical characteristics were compared with those of GOLD 1 and 2 patients. RESULTS: Among 2,741 patients, 374 GOLD 0, 206 grade 1, and 962 grade 2 patients were identified. GOLD 0 patients were characterized by high symptom burden, comparable to grade 2, and a restrictive lung function pattern; those with FEV1/FVC above 0.75 were unlikely to deteriorate over time into grades 1 and 2, in contrast to those with values between 0.70 and 0.75. Regarding mortality risk in GOLD 0, FEV1%predicted and age were the relevant determinants, whereby a cutoff value of 65% was superior to that of 80% as proposed previously. CONCLUSIONS: Regarding patients of the former GOLD grade 0, we identified simple criteria for FEV1/FVC and FEV1% predicted that were relevant for the outcome in terms of deterioration over time and mortality. These criteria might help to identify patients with the typical risk profile of COPD among those not fulfilling spirometric COPD criteria.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espirometria / Seleção de Pacientes / Doença Pulmonar Obstrutiva Crônica / Assistência ao Paciente Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espirometria / Seleção de Pacientes / Doença Pulmonar Obstrutiva Crônica / Assistência ao Paciente Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article